| Net loss | -9.08M |
| Depreciation | 555K |
| Stock-based compensation | 1.08M |
| Valuation of equity instruments | |
| Provision for doubtful accounts receivable | 9K |
| Amortization of intangible assets | |
| Amortization of discounts on long-term borrowings | |
| Deferred revenue | -93K |
| (Gain) / Loss on disposal of fixed assets | 35K |
| Accounts receivable, inventories, and other assets | 5.03M |
| Accounts payable and accrued liabilities | |
| Total adjustments | -4.58M |
| Net cash used in operating activities | |
| Acquisition of fixed assets | -1.48M |
| Proceeds from the sale of fixed assets | |
| Net cash used investing activities | |
| Proceeds from issuances of common stock, net | 0 |
| Proceeds from other borrowings | |
| Payments on other borrowings | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash | |
| Net (decrease) increase in cash and cash equivalents | -15.05M |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Cash and cash equivalents | |
| Restricted cash held | |
| Cash and cash equivalents at end of period | |